Patricia Carr - 05 Dec 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: SVP, Chief Accounting Officer
Issuer ticker: JAZZ
Reported as of: 05 Dec 2025
Net transaction value: -$164,768
SEC form: 4
Accepted by SEC: 09 Dec 2025, 17:25:20 UTC
Prior SEC filing: 20 Nov 2025
Next SEC filing: 21 Jan 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Patricia Carr

Key filing fact

Patricia Carr filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 09 Dec 2025.

Key facts

This page summarizes Patricia Carr's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Dec 2025, 17:25.

Change

Previous filing in this sequence was filed on 20 Nov 2025.
Current net transaction value: -$164,768.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001784606 Primary reporting owner

Carr Patricia

Relationship: SVP, Chief Accounting Officer
Address: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature: By: /s/Paz Dizon, as attorney in fact For: Patricia Carr
Signature date: 09 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $27,378
Shares: -160
Change %: -2.2%
Price: $171.11
Shares after: 7,012
Date: 05 Dec 2025
Ownership: Direct
Footnotes: F1

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value: $633,015
Shares: +4,500
Change %: +64%
Price: $140.67
Shares after: 11,512
Date: 05 Dec 2025
Ownership: Direct

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $770,405
Shares: -4,500
Change %: -39%
Price: $171.20
Shares after: 7,012
Date: 05 Dec 2025
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JAZZ transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -4,500
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 05 Dec 2025
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 4,500
Exercise price: $140.67
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The Reporting Person acquired 160 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025.

Footnote F2

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.2001 to $171.2601. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F3

These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option fully vested as of March 1, 2022.